RA women all N = 61 | MET-hours 1st quartile N = 14 | MET-hours 4th quartile N = 14 | P-value | |
---|---|---|---|---|
Age (years) | 60.8 (57.3-64.4) | 60.0 (57.0-65.0)* | 66.0 (63.0-76.0)* | 0.09 |
Ever smoker, N, (%) | 39 (64) | 11 (79) | 7 (50) | 0.29 |
RA duration* | 6.0 (2.0-15.0) | 4.5 (2.0-10.0) | 5.5 (2.0-14.0) | 0.68 |
DAS28 | 3.3 (3.0-3.6) | 3.4 (2.8-4.1) | 3.1 (2.3-3.9) | 0.32 |
ESR (mm/h)* | 16.0 (9.0-29.0) | 18.0 (13.0-21.0) | 10.0 (5.0-27.0) | 0.23 |
HAQ * | 0.5 (0.13-1.13) | 0.82 (0.25-1.0) | 0.63 (0.13-1.13) | 0.64 |
Patients on glucocorticoids, N, (%) | 17 (28) | 4 (31) | 3 (20) | 0.26 |
Glucocorticoids, mg* | 5.0 (2.50-5.0) | 3.12 (1.78-4.37) | 3.9 (2.5-5.0) | 0.54 |
Patients on anti-TNF, N, (%) | 15 (25) | 3 (23) | 4 (27) | 0.60 |
BMI (kg/m2)* | 24.2 (21.6-26.6) | 25.9 (23.6-29.5) | 22.8 (20.4-26.5) | 0.20 |
Waist (cm)* | 83.0 (75.0-91.5) | 87.2 (80.0-99.5) | 79.0 (72.0-90.0) | 0.11 |
Fat mass (%) | 37.8 (35.7-39.9) | 41.0 (36.1-45.9) | 35.1 (31.1-39.0) | 0.30 |
FMI (kg/m2)* | 8.8 (6.4-11.4) | 11.5 (8.4-14.7) | 6.6 (6.3-11.1) | 0.14 |
FFMI (kg/m2)* | 15.3 (14.6-16.2) | 17.5(14.7-17.1) | 15.3 (14.7-16.7) | 0.52 |
MET-hours* | 40.0 (37.4-44.7) | 35.9 (35.4-37.1) | 45.8 (45.2-49.2) | < 0.001 |